84 drug batches fail quality test, commonly used antacids, diabetes meds among them
24.02.2025
New Delhi : As many as 84 batches of drugs, including some commonly-prescribed steroids and cholesterol-lowering drugs, were found to be ‘not-of-standard quality’ in the latest round of inspections carried out by the drug control authorities across country. CDSCO, which is the apex body responsible for approval of new drugs & clinical trials, has issued an alert regarding this.
It issues alerts about nonstandard quality drugs being sold in the market monthly. According to its latest data, for Dec 2024, they found 84 batches of drugs manufactured by various firms to be of ‘not-of-standard quality’ (NSQ). This includes some of the drugs prescribed for common conditions such as acidity, high levels of cholesterol, diabetes and bacterial infections among others. Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters.
The failure is specific to the drug products of the batch tested by govt, officials said. “This action of identifying NSQ and spurious medicines is taken on a regular basis in collaboration with state regulators to ensure that these drugs are identified & removed from the market,” they added. Recently, CDSCO introduced new guidelines for inspections. It stated all drug inspectors in the country should collect at least 10 samples in a month; nine samples of drugs and one sample of cosmetics/ medical device. TNN
No comments:
Post a Comment